Paper Details

  1. Home
  2. Paper Details

A comparison of inhaled fenoterol and albuterol in asthma.

Author: HordvikN L, KönigP, SunderrajanE V

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Fenoterol and albuterol, both bronchodilators, were compared to placebo in asthmatic patients. Both drugs showed significant bronchodilation, with fenoterol providing a longer duration of effect but also more frequent side effects.
Paper Details　
Original Abstract of the Article :
In 24 adult asthmatics the effects of clinically recommended doses of fenoterol (320 micrograms) and albuterol (180 micrograms) were compared to placebo in a double-blind, crossover trial. Bronchodilation in FEV1 was significantly greater than placebo for both active drugs: two hours on albuterol an...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/4061978

データ提供：米国国立医学図書館（NLM）

Comparing Inhaled Fenoterol and Albuterol in Asthma: A Journey Through the Desert of Respiratory Conditions

The field of respiratory medicine frequently faces the challenge of managing asthma, a chronic respiratory condition. This study compares the effectiveness of inhaled fenoterol and albuterol, two common bronchodilators, in a double-blind, crossover trial with adult asthmatics. The authors aimed to assess the bronchodilator effects and duration of action of these medications.

Navigating the Shifting Sands of Asthma Treatment

The study found that both fenoterol and albuterol were significantly more effective than placebo in improving lung function. Fenoterol provided a longer duration of action than albuterol, but it also had a higher incidence of mild side effects. These findings highlight the importance of considering the specific needs and preferences of individual patients when choosing a bronchodilator.

Finding a Path Through the Desert of Asthma

This research offers valuable insights into the treatment of asthma, providing evidence for the effectiveness of both fenoterol and albuterol as bronchodilators. The study underscores the need for personalized treatment approaches, considering the individual patient's risk-benefit profile and desired duration of action. As we navigate the desert of asthma, understanding the nuances of different medications and their potential effects can help us find the right path to optimal lung function and symptom management.

Dr.Camel's Conclusion

This study offers a comprehensive guide to navigating the desert of asthma treatment. The authors' comparison of fenoterol and albuterol highlights the importance of considering both efficacy and side effects when choosing a bronchodilator. By carefully assessing individual patient needs and preferences, we can help asthmatics find the most effective and well-tolerated treatment to manage their condition.

Date :
  1. Date Completed 1985-12-18
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

4061978

DOI: Digital Object Identifier

4061978

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.